Welcome to the Weiner Research Lab

Precision Oncology

Lab objective

Merge patient data with highly annotated genomics to advance our ability to individualize cancer care

Deliver the right cancer treatment to the right patient at the right dose and the right time.”

-Schwartzberg et al. 2017 ASCO Educational Book

We are hiring!

We are looking for a Research Associate to lead and support

Current research funding

Weiner AB. Agrawal R. Wang NK. Sonni I. Li E. Arbet J. Zhang J. Proudfoot JA. Hong BH. Davicioni E. Kane K. Valle L. Kishan AU. Dal Pra A. Ghadjar P. Sweeney CJ. Nickols NG. Karnes RJ. Shen J. Rettig MB. Czernin J. Ross AE. Chua MLK. Schaeffer EM. Calais J. Boutros PC. Reiter RE. Molecular hallmarks of prostate-specific membrane antigen in treatment-naïve prostate cancer. Eur Urol. 2024, in press. PMID: 39294048

Weiner AB. Nguyen AV. Kishan AU. Reiter RE. Litwin MS. International variations in adherence to quality metrics for local-regional prostate cancer. Eur Urol Oncol. 2024, in Press. PMID: 38851994

Weiner AB. Kakani P. Armstrong AJ. Bossi A. Cornford P. Feng F. Kanabur P. Karnes RJ. McKay RR. Morgan TM. Schaeffer EM. Shore N. Tree AC. Spratt DE. Risk stratification of patients with recurrence after primary treatment for prostate cancer: A systematic review. Eur Urol. 2024, in Press. PMID: 38782697.

Weiner AB. Agrawal R. Valle LF. Sonni I. Kishan AU. Rettig MB. Raman SS. Calais J. Boutros PC. Reiter RE. Impact of PSMA PET on Prostate Cancer Management. Curr Treat Options Oncol. 25(2):191-205. Feb 2024. PMID: 38270802.

Weiner AB. Liu Y. Hakansson A. Zhao X. Proudfoot JA. Ho J. Zhang JH. Li EV. Karnes RJ. Den RB. Kishan AU. Reiter RE. Hamid AA. Ross AE. Tran PT. Davicioni E. Spratt DE. Attard G. Lotan TL. Chua MLK. Sweeney CJ. Schaeffer EM. A novel prostate cancer subtyping classifier based on luminal and basal phenotypes. Cancer. 129(14): 2169-2178. Jul 2023. PMID: 37060201

Weiner AB. Yu CY. Kini M. Liu Y. Davicioni E. Mitrofanova A. Lotan. TL. Schaeffer EM. High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments. Prostate Cancer Prostatic Dis. 26(1):105-112. Mar 2023. PMID: 35568781.

Weiner AB. Liu Y. Li EV. Zhao X. Li Z. Davicioni E. Lotan TL. Schaeffer EM. A transcriptomic model for homologous recombination deficiency in prostate cancer. Prostate Cancer Prostatic Dis. 25(4):659-665. April 2022. PMID: 34226663

Weiner AB. Li EV. Desai AS. Press DJ. Schaeffer EM. Cause of death during prostate cancer survivorship: A contemporary US population-based analysis. Cancer. 127(16): 2895-2904 Aug 2021. PMID: 33882145

Weiner AB. Vidotto T. Liu Y. Faisal FA. Murali S. McFarlane M. Imada EL. Zhao X. Li Z. Davicioni E. Marchionni L. Chinnaiyan AM. Freedland SJ. Spratt DE. Wu JD. Lotan TL. Schaeffer EM. Plasma cells are enriched in localized prostate cancer in Black men and are associated improved outcomes. Nat Commun. 12(1): 935. Feb 2021. PMID: 33568675

Recent Publications

Inquire about supporting Dr. Weiner’s research

Please fill out this form